The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Can targeting TSP-1 with gabapentin enhance survival in glioblastoma? A 20-year retrospective cohort study.
 
Mulki Mehari
No Relationships to Disclose
 
Vardhaan Ambati
No Relationships to Disclose
 
Saritha Krishna
No Relationships to Disclose
 
Mikias Negussie
No Relationships to Disclose
 
Cesar Nava Gonzales
No Relationships to Disclose
 
Abraham Dada
No Relationships to Disclose
 
Aymen Kabir
No Relationships to Disclose
 
Jasleen Kaur
No Relationships to Disclose
 
Sena Oten
No Relationships to Disclose
 
Youssef Sibih
No Relationships to Disclose
 
Andy Daniel
No Relationships to Disclose
 
John Frederick de Groot
Employment - Alaunos Therapeutics (I); Brii Biosciences (I)
Stock and Other Ownership Interests - Alaunos Therapeutics (I); Brii Biosciences (I); WuXi Biologics
Consulting or Advisory Role - Alpha Pharmaceutical; Aucentra Therapeutics; Bioasis Technologies; CarThera; Chimerix; Cure Brain Cancer Foundation; InSightec; Karyopharm Therapeutics; Kazia Therapeutics; Kintara Therapeutics; Merck; Midatech Pharma; Monteris Medical; Mundipharma Research; Samus Therapeutics; Sapience Therapeutics; SERVIER; Sumitomo Dainippon Pharma Oncology; Telix Pharmaceuticals; VBI Vaccines
Research Funding - CarThera (Inst); Haihe Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - Chimerix; VBI Vaccines
 
Yazmin Odia
Consulting or Advisory Role - GammaTile; Istari; PharPoint Research
Research Funding - Bristol-Myers Squibb (Inst); Novocure (Inst)
(OPTIONAL) Uncompensated Relationships - Actuate Therapeutics; Chimerix
 
Shawn L. Hervey-Jumper
Consulting or Advisory Role - Gilmartin Capital